Myocardial infarction, Arg 506 to Gin factor V mutation, and activated protein C resistance
- 1 February 1995
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 345 (8945), 321
- https://doi.org/10.1016/s0140-6736(95)90310-0
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Myocardial infarction associated with homozygous resistance to activated protein CThe Lancet, 1994
- Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.JCI Insight, 1994
- Arterial and venous thromboembolism with fatal outcome and resistance to activated protein CThe Lancet, 1994
- The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjectsBlood Coagulation & Fibrinolysis, 1994
- A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992